Aqua Medical, Inc.

We have a disruptive, endoscope based vapor ablation technology to prevent esophageal & pancreatic cancers and potentially treat diabetes

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Santa Ana, CA, US
  • Currency USD
  • Founded November 2016
  • Employees 1
  • Incorporation Type C-corp
  • Website aquaendoscopy.com

Company Summary

We have a disruptive, endoscope based vapor ablation technology to treat diseases throughout the GI tract. We target the prevention of esophageal and pancreatic cancers and potential to treat diabetes, all $ multi-billion potential markets.
We have a deeply experienced team with multiple exits, (up to $860M). We have a Mayo clinic founder & entrepreneur, physicians who are our investors, existing reimbursement and a strong patent portfolio.

Team

  • Lloyd Mencinger
    President & CEO

    Extensive blue chip company experience at Boston Scientific, Edwards Life Sciences, Baxter, Tenet Healthcare, SVP, General Management, Sales, Marketing, Business Development, Strategy & Operations roles. Early stage company experience includes GM roles at: Uptake Medical Inc., Endostim Inc., DFINE Inc, ($100 M exit). Extensive global experience, 12 years as expatriate. B.S. Chemical Engineering, MBA

  • Virender K. Sharma
    Founder & Chief Medical Officer

    Board Certified in Gastroenterology and Hepatology. Past Director of the Esophageal Clinic at the Mayo Clinic in Arizona. Published over 300 peer-reviewed articles. Successful companies include: EndoStim; raised $ 70M in venture funding; successful European commercialization; FDA PMA trial initiated. SynerZ Medical Inc. technology addressing obesity and diabetes. Fastest acquisition in recent GI Med-Tech history, after successful animal trials.

  • Greg Barrett
    Board of Directors

    CEO DFINE Inc, $100M acquisition by Merit Medical, CEO BARRX, $325M acquisition by Medtronic, CEO ACMI Circon, $500M acquisition by Olympus. Executive Vice President, Boston Scientific Corp. Group President Boston Scientific Corp. VP Global Sales & Marketing Orthofix, Vice President Global Sales & Marketing Baxter Bentley, V.P. Marketing C.R. Bard, Chairman of the Board Monteris Medical, Board of Directors Cutera, Board of Directors Barosense

  • Mark Gilreath
    Chairman of the Board

    CEO EndoChoice Inc, $225M acquisition by Boston Scientific, Given Imaging President Americas, $860M acquisition by Covidien/Medtronic, Given Imaging Vice President Corporate Strategy, Given Imaging Chief Marketing Officer CEO & Founder VortexMed Inc. Pentax Medical, Director of Business Development, Director of Marketing, Area Sales Manager U.S. Navy Officer, Naval Intelligence, Operation Desert Storm B.S. in Finance, MBA

  • Hazim Ansari
    Founder, Secretary

    Patent Counsel & CEO Novel IP, Founder SynerZ Medical. Advised numerous companies on patent portfolios, including Xerox, Fresenius Medical, Spacelabs Medical, Endochoice, Glucon, Xcorporeal, EndoStim, Lipid Sciences. Negotiated over 50 licensing deals. Co-founder Network Signatures, one of the largest patent royalty-generating revenue companies for the U.S. Navy. Loyola Law School graduated magna cum laude, Stanford University, B.S. Chem. E

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free